Upexi Discloses Substantial Executive Compensation Amidst Significant Losses and Ongoing Dilution
Summary
Upexi, Inc. filed its definitive proxy statement, revealing substantial executive compensation, including over $2.5 million for the CEO in 2025 and an additional $2.5 million in accrued bonus, despite reporting a $178.9 million net loss and having an active $500 million at-the-market offering.
Key Events
-
Annual Shareholder Meeting Scheduled
Upexi, Inc. will hold its Annual Meeting on June 15, 2026, to vote on the re-election of five directors and the ratification of GBQ Partners LLC as its independent registered public accounting firm.
-
High Executive Compensation Disclosed
CEO Allan Marshall's total compensation for fiscal year 2025 was $2,502,194, including over $1 million in option awards, with an additional $2,500,000 in accrued and unpaid bonus. CFO Andrew Norstrud received $844,385 in 2025, with an accrued bonus of $350,000.
-
New CSO Compensation Package
Brian Rudick, appointed Chief Strategy Officer in May 2025, has an annual salary of $300,000 and will receive $950,000 in structured cash payments through December 2025, plus 400,000 restricted stock shares.
-
Significant Insider Ownership
CEO Allan Marshall beneficially owns 5.58% of common stock and 100% of preferred stock, which converts to 138,889 common shares. Directors and executive officers as a group hold 9.00% of common stock and 100% of preferred stock.
Analysis
This definitive proxy statement, while routine in its proposals for director elections and auditor ratification, highlights significant concerns regarding corporate governance and executive compensation practices at Upexi. The disclosure of over $2.5 million in total compensation for the CEO in 2025, alongside an additional $2.5 million in accrued but unpaid bonus, is substantial for a company with a market capitalization of approximately $95 million. This level of executive pay is particularly notable given the company's recent report of a staggering $178.9 million net loss and the existence of a $500 million at-the-market offering, which signals ongoing potential for shareholder dilution. Investors may scrutinize the alignment of executive incentives with company performance and shareholder value, especially in light of the disclosed material weaknesses in internal controls.
At the time of this filing, UPXI was trading at $1.40 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $95.7M. The 52-week trading range was $0.54 to $15.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.